{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:37:30Z","timestamp":1751279850446},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p>In this report, we describe a case of a patient with a clinical history of systemic sarcoidosis and psoriasis who developed biopsy-confirmed perforating and necrotizing cutaneous granulomas after 12 months of treatment with adalimumab, a tumor necrosis factor-alpha\u2013inhibiting, anti-inflammatory, biologic medication, prescribed for the patient's psoriasis. Although rare reports of a \u201csarcoidosis-like\u201d reaction associated with select tumor necrosis factor-alpha agents exist, to the best of our knowledge, perforating and necrotizing cutaneous granulomas after treatment with adalimumab has not been previously reported. Given the patient's history of systemic sarcoidosis, the differential diagnosis includes reactivation of latent sarcoidosis with adalimumab as a trigger.<\/jats:p>","DOI":"10.1097\/dad.0000000000001394","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T20:30:45Z","timestamp":1551817845000},"page":"661-666","source":"Crossref","is-referenced-by-count":6,"title":["Necrotizing Granulomas in a Patient With Psoriasis and Sarcoidosis After Adalimumab\u2014Medication-Induced Reaction or Reactivation of Latent Disease?"],"prefix":"10.1097","volume":"41","author":[{"given":"Yana","family":"Turkowski","sequence":"first","affiliation":[{"name":"Dermatology Section, Department of Medicine, VA Boston Healthcare System, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nellie","family":"Konnikov","sequence":"additional","affiliation":[{"name":"Dermatology Section, Department of Medicine, VA Boston Healthcare System, MA;"},{"name":"Department of Dermatology, Tufts University School of Medicine, Boston, MA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Mahalingam","sequence":"additional","affiliation":[{"name":"Dermatopathology Section, Department of Pathology and Laboratory Medicine, VA Boston Healthcare System, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","first-page":"7","article-title":"Sarcoidosis: an update for the primary care physician","volume":"6","author":"Aladesanmi","year":"2004","journal-title":"Medscape Gen Med."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin Respir Crit Care Med."},{"key":"R3-20230908","first-page":"133","article-title":"Etiology of sarcoidosis: does infection play a role?","volume":"85","author":"Saidha","year":"2012","journal-title":"The Yale J Biol Med."},{"key":"R4-20230908","first-page":"1773","article-title":"Sarcoidosis at onset of psoriasis: a common immunopathogenesis. Review and case report","volume":"19","author":"Petroianni","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/j.1440-0960.2011.00863.x","article-title":"Development of cutaneous sarcoidosis during treatment with tumor necrosis factor- alpha antagonists","volume":"53","author":"Lamrock","year":"2012","journal-title":"Australas J Dermatol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonzalez-Lopez","year":"2006","journal-title":"Arthritis Rheum."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern Med."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis Rheum."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R12-20230908","first-page":"471","article-title":"Sarcoidosis occurring during anti-TNF-\u03b1 treatment for inflammatory rheumatic disease: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol."},{"key":"R13-20230908","first-page":"645","article-title":"Sarcoid-related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes","year":"2003","journal-title":"Clin Exp Rheumatol."},{"key":"R14-20230908","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J Rheumatol."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1592\/phco.27.10.1446","article-title":"Pulmonary sarcoidosis associated with etanercept therapy","volume":"27","author":"Farah","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R16-20230908","first-page":"349","article-title":"Granulomatous hepatitis associated with etanercept therapy","volume":"35","author":"Farah","year":"2008","journal-title":"J Rheumatol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000275676","article-title":"Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases","volume":"220","author":"Dhaille","year":"2010","journal-title":"Dermatology"},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis during infliximab therapy","volume":"55","author":"O\u2019Shea","year":"2006","journal-title":"Arthritis Rheum."},{"key":"R19-20230908","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almodovar","year":"2007","journal-title":"Clin Exp Rheumatol."},{"key":"R20-20230908","first-page":"2313","article-title":"Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab","volume":"34","author":"Sturfelt","year":"2007","journal-title":"J Rheumatol."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jbspin.2009.02.003","article-title":"Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient","volume":"76","author":"Josse","year":"2009","journal-title":"Joint Bone Spine"},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.semarthrit.2008.11.003","article-title":"Sarcoidosis appearing during anti-tumor necrosis factor \u03b1 therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review","volume":"39","author":"Massara","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/annrheumdis-2015-eular.5587","article-title":"Cutaneous and pulmonary sarcoidosis-like reaction associated with adalimumab: a case report","volume":"74","author":"Bilgici","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/thorax.58.3.278","article-title":"Pulmonary granulomas after tumor necrosis factor- alpha antagonist therapy","volume":"58","author":"Vavricka","year":"2003","journal-title":"Thorax"},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3899\/jrheum.090307","article-title":"Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge","volume":"36","author":"van der Stoep","year":"2009","journal-title":"J Rheumatol."},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10067-010-1603-3","article-title":"Sarcoid-like granulomatosis in patients treated with anti-TNF - alpha factors. A case report and review of the literature","volume":"30","author":"Kanellopoulou","year":"2011","journal-title":"Clin Rheumatol."},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10067-010-1577-1","article-title":"Tumor necrosis factor-alpha (TNF-alpha)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature","volume":"30","author":"Cuchacovich","year":"2011","journal-title":"Clin Rheumatol."},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognized complication","volume":"42","author":"Tong","year":"2012","journal-title":"Intern Med J."},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbspin.2012.05.001","article-title":"Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy","volume":"80","author":"Vigne","year":"2013","journal-title":"Joint Bone Spine."},{"key":"R30-20230908","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rmr.2010.08.018","article-title":"Pulmonary sarcoidosis developing during treatment with etanercept","volume":"28","author":"Kerjouan","year":"2011","journal-title":"Rev Mal Respir."},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.arbres.2010.05.011","article-title":"Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review","volume":"47","author":"Gifre","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"R32-20230908","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1590\/1806-9282.62.08.718","article-title":"Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept","volume":"62","author":"Viera","year":"2016","journal-title":"Rev Assoc Med Bras"},{"key":"R33-20230908","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20230908","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3899\/jrheum.080383","article-title":"Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis","volume":"35","author":"Ognenovski","year":"2008","journal-title":"J Rheumatol."},{"key":"R35-20230908","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.crohns.2012.01.008","article-title":"Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab","volume":"6","author":"Fok","year":"2012","journal-title":"J Crohns Colitis."},{"key":"R36-20230908","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","article-title":"Relapse of sarcoidosis upon treatment with etanercept","volume":"67","author":"Louie","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"R37-20230908","first-page":"1222","article-title":"Cutaneous granulomas during infliximab therapy for spondyloarthropathy","volume":"35","author":"Dubosc","year":"2008","journal-title":"J Rheumatol."},{"key":"R38-20230908","first-page":"53","article-title":"Adalimumab induced pulmonary sarcoid reaction","volume":"10","author":"Bhargava","year":"2013","journal-title":"Respir Med Case Rep."},{"key":"R39-20230908","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Dermatol."},{"key":"R40-20230908","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2010.08.019","article-title":"Drug-Induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab","volume":"56","author":"Korsten","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"R41-20230908","first-page":"281","article-title":"Cutaneous side effects of TNF-alpha inhibitors","volume":"15","author":"Lindhaus","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"R42-20230908","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4103\/0019-5154.91847","article-title":"Disseminated granuloma annulare: a cutaneous adverse effect of anti-TNF agents","volume":"56","author":"Ratnarathorn","year":"2011","journal-title":"Indian J Dermatol."},{"key":"R43-20230908","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","article-title":"Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept","volume":"46","author":"Kekow","year":"2002","journal-title":"Arthritis Rheum."},{"key":"R44-20230908","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum."},{"key":"R45-20230908","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2125.2006.02581.x","article-title":"Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis","volume":"62","author":"Nestorov","year":"2006","journal-title":"Br J Clin Pharmacol."},{"key":"R46-20230908","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40262-017-0627-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of infliximab in the treatment of inflammatory bowel disease","volume":"57","author":"Hemperly","year":"2018","journal-title":"Clin Pharmacokinet."},{"key":"R47-20230908","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bcp.12509","article-title":"Pharmacokinetics and concentration\u2013effect relationship of adalimumab in rheumatoid arthritis","volume":"79","author":"Ternant","year":"2015","journal-title":"Br J Clin Pharmacol."},{"key":"R48-20230908","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cup.12253","article-title":"Transepithelial elimination in sarcoidosis: a frequent finding","volume":"41","author":"Ismail","year":"2014","journal-title":"J Cutan Pathol."},{"key":"R49-20230908","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0190-9622(86)70016-9","article-title":"Transepithelial elimination of granulomas in cutaneous tuberculosis and sarcoidosis","volume":"14","author":"Goette","year":"1986","journal-title":"J Am Acad Dermatol."},{"key":"R50-20230908","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000372-199306000-00002","article-title":"Cutaneous sarcoidosis and foreign bodies","volume":"15","author":"Walsh","year":"1993","journal-title":"Am J Dermatopathol"},{"key":"R51-20230908","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archderm.1991.01680040100011","article-title":"Cutaneous silica granuloma. A rare entity or rarely diagnosed? Report of two cases with review of the literature","volume":"127","author":"Mowry","year":"1991","journal-title":"Arch Dermatol."},{"key":"R52-20230908","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(09)61057-6","article-title":"Silica in oral drugs as a possible sarcoidosis-inducing antigen","volume":"373","author":"Sola","year":"2009","journal-title":"Lancet"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:38:35Z","timestamp":1721043515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001394","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}